Subscribe to Newsletter

Biosimilars

Discovery & Development Biosimilars

I’m a (Biosimilars) Believer!

| Stephanie Vine

Why does the full potential of biosimilars remain untapped? Four experts weigh in.
Business & Regulation Biosimilars

Business in Brief

| Stephanie Vine

The latest business news and views in pharma.
Manufacture Biosimilars

Open Your Mind

| Roisin McGuigan

Why is the pharma industry overly reluctant to accept new ideas?
Manufacture Standards & Regulation

Raising the Biosimilar Banner

| Stephanie Vine

FDA Commissioner Scott Gottlieb wants more biosimilars on the US market.
Business & Regulation Biosimilars

Breaking Barriers to Biosimilars

| James Strachan

Sitting Down With… Richard Markus, Vice President of Global Development, Amgen, USA
Business & Regulation Biosimilars

Business-in-Brief

| William Aryitey

EMA relocation, a price-fixing scandal, and FDA warning letters… What's new for pharma in business?
Discovery & Development Biosimilars

Champion of Generics

| Abhijit Mukherjee

Sitting Down With… Abhijit Mukherjee, COO of Dr. Reddy's Laboratories, India
Discovery & Development Biosimilars

Being (Bio)Better

| Darrell Sleep

Why stop at biosimilar when you can be biobetter?
Business & Regulation Biosimilars

Generating Generics Faster

| William Aryitey

The FDA aims to reduce drug prices with a more competitive market - and generics are key.
Manufacture Formulation

Pulling for a Cure: Lessons Learned with John Lambert

| James Strachan

John Lambert talks antibody-drug conjugates and his involvement with Kadcyla.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

October Issue of The Medicine Maker